Eli Lilly stock undercut its 50-day line on Jan. 14 after cutting its fourth-quarter and 2024 outlook. Is LLY stock a sell ...
Oppenheimer maintained its Outperform rating on Goldman Sachs (NYSE:GS) stock and increased the price target to $687 from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback